El-Shafie, S.; Fahmy, S.A.; Ziko, L.; Elzahed, N.; Shoeib, T.; Kakarougkas, A.
Encapsulation of Nedaplatin in Novel PEGylated Liposomes Increases Its Cytotoxicity and Genotoxicity against A549 and U2OS Human Cancer Cells. Pharmaceutics 2020, 12, 863.
https://doi.org/10.3390/pharmaceutics12090863
AMA Style
El-Shafie S, Fahmy SA, Ziko L, Elzahed N, Shoeib T, Kakarougkas A.
Encapsulation of Nedaplatin in Novel PEGylated Liposomes Increases Its Cytotoxicity and Genotoxicity against A549 and U2OS Human Cancer Cells. Pharmaceutics. 2020; 12(9):863.
https://doi.org/10.3390/pharmaceutics12090863
Chicago/Turabian Style
El-Shafie, Salma, Sherif Ashraf Fahmy, Laila Ziko, Nada Elzahed, Tamer Shoeib, and Andreas Kakarougkas.
2020. "Encapsulation of Nedaplatin in Novel PEGylated Liposomes Increases Its Cytotoxicity and Genotoxicity against A549 and U2OS Human Cancer Cells" Pharmaceutics 12, no. 9: 863.
https://doi.org/10.3390/pharmaceutics12090863
APA Style
El-Shafie, S., Fahmy, S. A., Ziko, L., Elzahed, N., Shoeib, T., & Kakarougkas, A.
(2020). Encapsulation of Nedaplatin in Novel PEGylated Liposomes Increases Its Cytotoxicity and Genotoxicity against A549 and U2OS Human Cancer Cells. Pharmaceutics, 12(9), 863.
https://doi.org/10.3390/pharmaceutics12090863